Sex differences in acute stroke metrics and outcome dependent on COVID status

Lukas Mayer‐Suess,João Pedro Marto,Davide Strambo,George Ntaios,Thanh Nguyen,Stefan Kiechl,Raimund Pechlaner,Raul Nogueira,Patrik Michel,Michael Knoflach,for the Global COVID19 Stroke Registry
DOI: https://doi.org/10.1111/ene.16221
2024-01-31
European Journal of Neurology
Abstract:Background and purpose Biological sex is known to have an impact on quality metrics of acute stroke. We aimed to determine whether COVID positivity accentuates this effect and constitutes worse outcome. Methods The present analysis was based on the Global COVID‐19 Stroke Registry, a retrospective, international, cohort study of consecutive ischemic stroke patients receiving intravenous thrombolysis and/or endovascular thrombectomy between 1 March 2020 and 30 June 2021. We investigated differences between the sexes in patient characteristics, acute stroke metrics as well as post‐stroke outcome in COVID‐positive and COVID‐negative stroke patients undergoing acute revascularization procedures. Results A total of 15,128 patients from 106 centers were recorded in the Global COVID‐19 Stroke Registry, 853 (5.6%) of whom were COVID‐positive. Overall, COVID‐positive individuals were treated significantly slower according to every acute stroke metric compared to COVID‐negative patients. We were able to show that key quality indicators in acute stroke treatment were unfavorable for COVID‐negative women compared to men (last‐seen‐well‐to‐door time + 11 min in women). Furthermore, COVID‐negative women had worse 3‐month outcomes (3‐month modified Rankin Scale score [interquartile range] 3.0 [4.0] vs. 2.0 [3.0]; p
neurosciences,clinical neurology
What problem does this paper attempt to address?